Remove Communication Remove Drug Development Remove Pharmaceutical Companies
article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

This shift has led to the emergence of integrated contract development and manufacturing organizations (CDMOs), which provide end-to-end support for drug developers. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 from 2023 to 2030.

article thumbnail

Deep Dive: Communications and Commercialisation

pharmaphorum

The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. The pharma company’s senior vice president for major markets talks about the continued evolution of the industry’s approach to communications and commercialisation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD). Let’s break them down below.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

article thumbnail

Building an Effective Pharma Network: Strategies for Expanding Influence in Pharma Marketing

Pharma Marketing Network

Understanding the Dynamics of Pharma Networks Pharma networks are intricate systems composed of various stakeholders, including pharmaceutical companies, healthcare professionals, regulatory bodies, and patients. Understanding the dynamics of these networks is essential for any entity looking to thrive in the pharmaceutical sector.

article thumbnail

Digital innovation drives vaccine development

pharmaphorum

The digital transformation is allowing pharmaceutical companies to expand their drug discovery capabilities and accelerate drug development. Access to and awareness of vaccines is more important than ever, especially in a globally connected world where outbreaks cannot easily be confined to a limited area.